| Status | Study |
| Recruiting |
Study Name: Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Condition: Acinar Cell Carcinoma Adrenal Cortex Carcinoma Date: 2016-07-13 Interventions: Procedure: Biospecimen Collection |
| Recruiting |
Study Name: High Volume Washing of the Abdomen in Increasing Survival After Surgery in Patients With Pancreatic Cancer That Can Be Removed by Surgery Condition: Acinar Cell Carcinoma Ampulla of Vater Adenocarcinoma Date: 2016-04-29 Interventions: Procedure: Pancreatectomy Unde |
| Suspended |
Study Name: Selinexor, Gemcitabine Hydrochloride, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Metastatic Pancreatic Cancer Condition: Acinar Cell Adenocarcinoma of the Pancreas Duct Cell Adenocarci Date: 2014-06-23 Interventions: Drug: gemcitabine hydrochloride |
| Recruiting |
Study Name: Stereotactic Radiosurgery and Metformin Hydrochloride in Treating Patients With Borderline-Resectable or Locally-Advanced Pancreatic Cancer Condition: Acinar Cell Adenocarcinoma of the Pancreas Duct Cell Adenocarci Date: 2014-05-30 Interventions: Drug: metformin hydrochloride |
| Recruiting |
Study Name: Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer Condition: Acinar Cell Adenocarcinoma of the Pancreas Duct Cell Adenocarci Date: 2014-01-24 Interventions: Drug: oxaliplatin Given IV |
| Active, not recruiting |
Study Name: Alisertib and Gemcitabine Hydrochloride in Treating Patients With Solid Tumors or Pancreatic Cancer Condition: Acinar Cell Adenocarcinoma of the Pancreas Duct Cell Adenocarci Date: 2013-08-13 Interventions: Drug: alisertib Given PO |
| Completed |
Study Name: CPI-613 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer Condition: Acinar Cell Adenocarcinoma of the Pancreas Duct Cell Adenocarci Date: 2013-04-23 Interventions: Drug: 6,8-bis(benzylthio)octanoic acid Given IV Othe |
| Active, not recruiting |
Study Name: CPI-613 and Combination Chemotherapy in Treating Patients With Metastatic Pancreatic Cancer Condition: Acinar Cell Adenocarcinoma of the Pancreas Duct Cell Adenocarci Date: 2013-04-16 Interventions: Drug: 6,8-bis(benzylthio)octanoic acid |
| Recruiting |
Study Name: ADH-1, Gemcitabine Hydrochloride and Cisplatin in Treating Patients With Metastatic Pancreatic or Biliary Tract Cancer That Cannot Be Removed By Surgery Condition: Acinar Cell Adenocarcinoma of the Pancreas Adenocarcinoma of th Date: 2013-03-27 Interventions: Drug: ADH-1 Given IV |
| Active, not recruiting |
Study Name: Chemotherapy and Radiation Therapy Before Surgery Followed by Gemcitabine in Treating Patients With Pancreatic Cancer Condition: Acinar Cell Adenocarcinoma of the Pancreas Duct Cell Adenocarci Date: 2013-03-25 Interventions: Drug: oxaliplatin IV |